Epi-Sense Guided Coagulation System With Visitrax
Payments companies reported to CMS as associated with Epi-Sense Guided Coagulation System With Visitrax. "Associated with" is CMS's wording: it links a payment to a product without saying the money was spent on it.
By year
Payments reported as associated with Epi-Sense Guided Coagulation System With Visitrax, per program year, as reported to CMS.
Who makes it
Specialties most often involved
Where the associated payments went, by the receiving clinician's specialty.
Clinicians most associated with Epi-Sense Guided Coagulation System With Visitrax
These are the largest totals companies reported as associated with Epi-Sense Guided Coagulation System With Visitrax. They are typically speaking or consulting arrangements, which companies must report by law; appearing here is not evidence of anything improper.
| Clinician | Location | Specialty | Associated payments (2023-2025) |
|---|---|---|---|
| Kevin Makati | Lutz, FL | Cardiovascular Disease | $281,495.46 |
| Nitesh Sood | Fall River, MA | Clinical Cardiac Electrophysiology | $235,288.63 |
| Zayd Eldadah | Washington, DC | Clinical Cardiac Electrophysiology | $147,817.95 |
| Armin Kiankhooy | Saint Helena, CA | Thoracic Surgery (Cardiothoracic Vascular Surgery) | $146,918.03 |
| Justin Van Meeteren | Kansas City, MO | Thoracic Surgery (Cardiothoracic Vascular Surgery) | $146,096.82 |
| Gansevoort Dunnington | Saint Helena, CA | Thoracic Surgery (Cardiothoracic Vascular Surgery) | $144,115.97 |
| David Delurgio | Atlanta, GA | Clinical Cardiac Electrophysiology | $129,936.58 |
| Tara Mudd | Louisville, KY | Nurse Practitioner | $116,093.38 |
| Andrew Sherman | Tampa, FL | Thoracic Surgery (Cardiothoracic Vascular Surgery) | $114,149.76 |
| Andreas Kamlot | Danville, CA | Surgery | $109,040.20 |
Prescribed Epi-Sense Guided Coagulation System With Visitrax?
See what its makers reported for your doctor. Two steps, private, no account.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.